P/E Ratio Insights for Johnson & Johnson
Portfolio Pulse from Benzinga Insights
Johnson & Johnson Inc. (NYSE:JNJ) stock is currently trading at $171.79, after a 0.67% increase. Over the past month, the stock increased by 7.87%, and in the past year, by 0.89%. The company's P/E ratio is 34.61, lower than the aggregate P/E ratio of 40.51 in the Pharmaceuticals industry. This could indicate that the stock is undervalued or that shareholders do not expect the stock to perform better in the future.
August 04, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Johnson & Johnson's stock is trading at $171.79, up 0.67%. Its P/E ratio is 34.61, lower than the industry average, which could indicate undervaluation or lower future performance.
The P/E ratio is a key indicator of a stock's value. Johnson & Johnson's lower P/E ratio compared to the industry average could indicate that the stock is undervalued, which would be a positive for the stock. However, it could also mean that investors do not expect the stock to perform as well in the future, which would be a negative. Therefore, the impact on the stock is neutral in the short term.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100